Athenex Pharmaceutical Division Receives FDA Clearance to Import Potassium Chloride Injection Concentrate to Address U.S. Drug Shortage Biotech Investing
Neuralstem Announces NSI-189 Granted Orphan Drug Designation from the U.S. FDA for the Treatment of Angelman Syndrome Biotech Investing
BeiGene Announces Closing of Its HK$7.08 billion (US$903 million) Hong Kong Initial Public Offering and Global Offering Pharmaceutical Investing
Paratek Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee to Review Omadacycline New Drug Applications Pharmaceutical Investing
INSYS Therapeutics Reaches Agreement in Principle to Settle Department of Justice Investigation Pharmaceutical Investing
FDA Advisory Committee Votes 12-2 in Favor of the Safety and Effectiveness of Insmed’s ALIS for the Treatment of NTM Lung Disease Caused by MAC for Adult Patients with Limited or No Treatment Options Biotech Investing
Synergy Pharmaceuticals Announces License Agreement with Luoxin Pharmaceutical Group for TRULANCE (plecanatide) in China Life Science Investing
ACADIA Pharmaceuticals and Neuren Pharmaceuticals Announce Exclusive License Agreement Pharmaceutical Investing
